EGENS GROUP is a joint venture and a leading IVD solution provider that develops, manufactures and distributes diagnostic kits worldwide. The company offers products such as rapid tests, ELISA kits, and CLIA and POCT analyzer systems.
The SARS-CoV-2 Neutralizing Antibody Rapid Test Kit is a solid phase immunochromatographic assay for the in vitro qualitative detection of neutralizing antibody in human serum, plasma and whole blood after vaccination against 2019-nCoV. The product is designed to determine whether people have produced neutralizing antibody after being vaccinated with 2019-nCoV vaccine.
The COVID-19 Antigen Rapid Test Kit is a solid phase immunochromatographic assay for the in vitro qualitative detection of antigen to 2019 Novel Coronavirus in human nasopharyngeal secretion or oropharyngeal secretion. The test kit provides only a preliminary test result for COVID-19 infection as a clinically-assisted diagnosis. The test kit is applicable to clinical system, medical institutions and scientific research field.
The COVID-19 IgG/IgM Rapid Test Kit is a solid phase immunochromatographic assay for the rapid, qualitative and differential detection of IgG and IgM antibodies to 2019 Novel Coronavirus in human whole blood, serum or plasma. The test provides only a preliminary test result. Therefore, any reactive specimen with the COVID-19 IgG/IgM Rapid Test kit must be confirmed with alternative testing method(s) and clinical findings.
EGENS GROUP is a joint venture and a leading IVD solution provider that develops, manufactures and distributes diagnostic kits worldwide. The company offers products such as rapid tests, ELISA kits, and CLIA and POCT analyzer systems.
The ELINE TB rapid screen test is a chromatographic immunoassay for the qualitative detection of antibodies to M. tuberculosis in human serum. The rapid test can identify antibodies to with a high degree of accuracy tanks to three specially selected TB recombinant proteins used in the test band as capture materials and gold conjugates.
The ELINE TP rapid screen test is a chromatographic immunoassay for the qualitative detection of antibodies to Treponema Pallidum (TP) in human serum. The one step test is very sensitive and takes only about 15 minutes while allowing the test results to be read visually without any instrument.
The Esign HBcAb ELISA test is an enzyme-linked immunosorbent assay for the qualitative identification of antibodies to hepatitis B antigen (HBcAg) in human serum/plasma. It is intended for clinical lab diagnosis and handling of hepatitis B-infected patients.
The ELINE TB rapid screen test is a chromatographic immunoassay for the qualitative detection of antibodies to M. tuberculosis in human serum. The rapid test can identify antibodies to with a high degree of accuracy tanks to three specially selected TB recombinant proteins used in the test band as capture materials and gold conjugates.
The ELINE TP rapid screen test is a chromatographic immunoassay for the qualitative detection of antibodies to Treponema Pallidum (TP) in human serum. The one step test is very sensitive and takes only about 15 minutes while allowing the test results to be read visually without any instrument.
The Esign HBcAb ELISA test is an enzyme-linked immunosorbent assay for the qualitative identification of antibodies to hepatitis B antigen (HBcAg) in human serum/plasma. It is intended for clinical lab diagnosis and handling of hepatitis B-infected patients.
The Esign HBsAg ELISA Test is an enzyme-linked immunosorbent assay for the qualitative identification of HBsAg in human serum/plasma. It is one of the best methods available for either screening blood donors or in the clinical diagnosis of hepatitis B-infected individuals.
The COVID-19 IgG/IgM Rapid Test Kit is a solid phase immunochromatographic assay for the rapid, qualitative and differential detection of IgG and IgM antibodies to 2019 Novel Coronavirus in human whole blood, serum or plasma. The test provides only a preliminary test result. Therefore, any reactive specimen with the COVID-19 IgG/IgM Rapid Test kit must be confirmed with alternative testing method(s) and clinical findings.
The COVID-19 Antigen Rapid Test Kit is a solid phase immunochromatographic assay for the in vitro qualitative detection of antigen to 2019 Novel Coronavirus in human nasopharyngeal secretion or oropharyngeal secretion. The test kit provides only a preliminary test result for COVID-19 infection as a clinically-assisted diagnosis. The test kit is applicable to clinical system, medical institutions and scientific research field.
The SARS-CoV-2 Neutralizing Antibody Rapid Test Kit is a solid phase immunochromatographic assay for the in vitro qualitative detection of neutralizing antibody in human serum, plasma and whole blood after vaccination against 2019-nCoV. The product is designed to determine whether people have produced neutralizing antibody after being vaccinated with 2019-nCoV vaccine.
